Pharmaceutical Preformulation Studies

Preformulation commences once a fresh synthesized drug shows sufficient pharmacological promise in animal models to warrant analysis in man. These studies should focus on those physicochemical properties of the new compound that could affect drug performance and development of an efficacious dosage form. A thorough understanding of these properties may ultimately provide a rational for formulation design or support the need for molecular modification. This review article focus on the various Preformulation factors which effect the development of new dosage form like drug solubility, partition coefficient, dissolution rate, polymorphic forms and stability

Every drug has intrinsic chemical and physical properties that has been contemplate before development of pharmaceutical formulation. This property provides the framework for drug’s combination with pharmaceutical ingredients. Preformulation studies applied by varied analysis scientists are reviewed. Preformulation studies conduct for fresh synthesized compounds or extracted compound and it offers the knowledge relating to the degradation method, any adverse conditions relevant to the drug, bioavailability, pharmacokinetics and formulation of similar compound and toxicity

Preformulation studies strengthen the scientific foundation of the guidance, provide regulatory relief and conserve resources in the drug development and evaluation process, improve public safety standards, enhance product quality in the fabrication of dosage form. Objective of Preformulation study is to develop the elegant, stable, effective and safe dosage form by establishing kinetic rate profile, compatibility with the other ingredients and establish Physio-chemical parameter of new drug substances.

Polymorphism having crystal and amorphous forms shows totally different chemical physical and therapeutic description of the drug molecule.

 

    Related Conference of Pharmaceutical Preformulation Studies

    November 26-27, 2024

    3rd World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2024

    3rd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 28-29, 2024

    39th World Congress on Pharmacology and Therapeutics

    Paris, France
    November 28-29, 2024

    12th International Conference on Clinical Trials

    Vancouver, Canada
    February 24-25, 2025

    2nd International Conference on Pharmacognosy

    Madrid, Spain
    March 10-11, 2025

    35th Annual European Pharma Congress

    Rome, Italy
    March 13-14, 2025

    8th International on Pharmacy and Pharmaceutical Conference

    Prague, Czech Republic
    April 14-15, 2025

    18th European Biosimilars Congress

    Paris, France
    April 24-25, 2025

    18th World Drug Delivery Summit

    London, UK
    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    July 24-25, 2025

    5th World Congress on Cardiovascular Medicine Pharmacology

    Aix-en-Provence, France
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    October 22-23, 2025

    7th European Conference on Advance Clinical Trials and Research

    Aix-en-Provence, France

    Pharmaceutical Preformulation Studies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in